Curtiss-Wright (CW) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Q1 2025 sales reached $806 million, up 13% year-over-year, with operating income up 34% to $134 million and diluted EPS up 42% to $2.82, driven by strong performance across all segments and robust defense demand.
Record new orders of $1.0 billion, up 13%, with a book-to-bill ratio of 1.26x and backlog exceeding $3.6 billion, providing strong visibility for future growth.
Free cash flow improved 5% year-over-year in Q1, despite typical seasonal outflow, and cash flow conversion is expected to exceed 105% for 2025.
Raised full-year 2025 guidance for sales, operating margins, and EPS, reflecting confidence in continued momentum and operational efficiency initiatives.
Net earnings increased 32% to $101 million, with comprehensive income reaching $120 million, up from $61 million in the prior year.
Financial highlights
Q1 2025 sales reached $806 million, up from $713 million in Q1 2024 (+13%), with 11% organic growth.
Adjusted operating income rose 34% to $134 million, with margin expanding to 16.6% from 14.0% year-over-year.
Diluted EPS was $2.82, up 42% year-over-year; basic EPS was $2.69, up from $2.00.
Gross profit increased to $292 million from $254 million year-over-year.
Free cash flow was negative $55 million, a $3 million improvement year-over-year, reflecting higher cash earnings and increased capital investments.
Outlook and guidance
Full-year 2025 sales guidance raised to $3.365–$3.415 billion, up 8–9% from 2024, with 5–7% organic growth.
Operating margin guidance increased to 18.3–18.5%, up 80–100 basis points year-over-year.
Diluted EPS guidance raised to $12.45–$12.80, up 14–17% year-over-year.
Free cash flow guidance increased to $495–$515 million, reflecting >105% FCF conversion and higher capex for growth.
Guidance incorporates potential direct impacts from tariffs and mitigating actions.
Latest events from Curtiss-Wright
- Record 2024 results and strong 2025 outlook driven by A&D and nuclear market growth.CW
Q4 20248 Jul 2026 - Q2 sales up 11%, adjusted EPS up 24%, and 2024 guidance raised on strong A&D demand.CW
Q2 20248 Jul 2026 - Strong defense, nuclear, and aerospace growth, fueled by innovation and strategic capital use.CW
Morgan Stanley’s 13th Annual Laguna Conference8 Jul 2026 - Raised 2026 guidance after strong Q1 sales, margin, and EPS growth across all segments.CW
Q1 20268 Jul 2026 - Q3 2024 saw double-digit sales growth, record backlog, and raised guidance, led by defense and naval.CW
Q3 20248 Jul 2026 - Growth and innovation fuel rising sales and margins in defense, aerospace, and nuclear markets.CW
46th Annual William Blair Growth Stock Conference4 Jun 2026 - 2026 sales and margins set to rise, fueled by innovation, backlog, and nuclear market upside.CW
Investor presentation3 Jun 2026 - Strong defense, nuclear, and international growth with robust order books and disciplined capital allocation.CW
19th Annual Global Transportation & Industrials Conference25 May 2026 - 2026 guidance projects robust growth, margin expansion, and strong cash flow, with nuclear upside.CW
Investor presentation8 May 2026